Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ilaria Gritti, Ph.D.

Concepts (44)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ilaria Gritti's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ilaria Gritti has written about over time.
Burkitt Lymphoma, 1 publications between 2016 and 2016, average publication date November 2016. Proto-Oncogene Proteins c-myc, 2 publications between 2016 and 2018, average publication date June 2017. DNA Repair, 1 publications between 2022 and 2022, average publication date October 2022. Genomic Instability, 1 publications between 2022 and 2022, average publication date October 2022. Multiple Myeloma, 1 publications between 2022 and 2022, average publication date October 2022. Ribonucleases, 1 publications between 2022 and 2022, average publication date October 2022. RNA, 1 publications between 2022 and 2022, average publication date October 2022. Dexmedetomidine, 1 publications between 2024 and 2024, average publication date July 2024. Magnesium Sulfate, 1 publications between 2024 and 2024, average publication date July 2024. Nerve Block, 1 publications between 2024 and 2024, average publication date July 2024. Osteotomy, 1 publications between 2024 and 2024, average publication date July 2024. Pain, Postoperative, 1 publications between 2024 and 2024, average publication date July 2024. Immune Evasion, 1 publications between 2024 and 2024, average publication date July 2024. Isocitrate Dehydrogenase, 1 publications between 2024 and 2024, average publication date July 2024.

To see the data from this visualization as text, click here.
Gritti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (44)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.